Malaysia vs Singapore: Hepatitis B surface antigen (HBsAg) prevalence
Malaysia
0.1%
in 2024
Singapore
0.1%
in 2024
Malaysia rank
101st
Singapore rank
101st
Hepatitis B surface antigen (HBsAg) prevalence over time
- Malaysia
- Singapore
How they compare
Malaysia currently reports 0.1% against 0.1% in Singapore, a difference of 0.0%.
The two have swapped places 2 times across 10 shared years of data; in 2015 it was Singapore ahead.
Malaysia ranks 101st and Singapore ranks 101st of 194 countries.
Malaysia has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Malaysia | Singapore | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 0.2% | 0.1% | 0.0% | Malaysia |
| 2020s | 0.1% | 0.1% | 0.0% | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hepatitis b surface antigen (hbsag) prevalence, Malaysia or Singapore?
- Malaysia, at 0.1% against 0.1% in Singapore as of 2024.
- What is the difference in hepatitis b surface antigen (hbsag) prevalence between Malaysia and Singapore?
- 0.0%, with Malaysia ahead.
- How many years of comparable data are there for Malaysia and Singapore?
- 10 years are reported by both, from 2015 to 2024.
- How do Malaysia and Singapore rank globally for hepatitis b surface antigen (hbsag) prevalence?
- Malaysia ranks 101st and Singapore ranks 101st of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Hepatitis B surface antigen (HBsAg) prevalence (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.